Indian generic drugmaker gets FDA warning over clinical study consent

July 21, 2026 01:22 PM EDT PharmaFDA+ In­di­an gener­ic drug­mak­er gets FDA warn­ing over clin­i­cal study con­sent Anna Brown News Reporter In­di­an gener­ic drug­mak­er Alem­bic Phar­ma­ceu­ti­cals has been hit with an FDA warn­ing let­ter af­ter fail­ing to get in­formed con­sent from pa­tients for a clin­i­cal study. … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER